Acuere Biosciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 K
- Paid Up Capital ₹ 10.00 K
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Acuere Biosciences
Acuere Biosciences Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 July 2019 (Five years and seven months 27 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 K and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sakshi Joshi, Shantanu Joshi, and Spruha Joshi serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110PN2019PTC185235
- Company No.
185235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Healthcare
Who are the key members and board of directors at Acuere Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shantanu Joshi  | Director | 27-Jun-2023 | Current |
| Sakshi Joshi | Director | 04-Jul-2019 | Current |
| Spruha Joshi | Director | 21-Mar-2023 | Current |
Financial Performance of Acuere Biosciences.
Acuere Biosciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Acuere Biosciences?
Unlock access to Acuere Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Inducare Pharmaceuticals And Research FoundationShantanu Joshi is a mutual person
Acuere Lifescience FoundationSakshi Joshi, Shantanu Joshi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Acuere Biosciences?
Acuere Biosciences has a workforce of 10 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acuere Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acuere Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.